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a b s t r a c t
ES-62 is an immunomodulatory phosphorylcholine (PC)-containing glycoprotein secreted by the rodent
ﬁlarial nematode Acanthocheilonema viteae. Previously, the use of knockout mice has revealed the effects
of ES-62 on macrophages and dendritic cells to be dependent on TLR4. However, it is possible that ES-62
may interact with additional proteins on the surfaces of target cells and hence that cells may vary with
respect to receptor usage. In this study, we identiﬁed by molecular weight, proteins that interact with ES-
62 and found differences amongst the immune system cells studied. Thus, whereas lymphocytes appear
to have two major interacting proteins of 135 and 82 kDa, U937 monocytes only contain an ES-62-
binding protein of the latter molecular weight. Binding to the proteins on B cells and U937 cells was
blocked by PC, suggesting a critical role for this ES-62 moiety in facilitating interaction. Finally, ES-62
binding is followed by internalization in both macrophages and B cells but only in the former was
absence of TLR4 found to block internalization. These ﬁndings are consistent with differences in receptor
usage by ES-62 amongst different cell-types.
 2011 Elsevier Inc. All rights reserved.
1. Introduction
Parasitic helminths pose signiﬁcant health problems for hu-
mans and also their domestic animals and livestock. This knowl-
edge has resulted in widespread attempts to design vaccines and
although these have been largely unsuccessful a great deal has
been learned about the immunological relationship between hel-
minth and host (reviewed in Maizels et al. (1999), Moreau and
Chauvin (2010)). It is now clear that parasitic helminths have
evolved a number of strategies for interfering with or modulating
the immune system of the parasitized host (reviewed in Maizels
and Yazdanbakhsh (2003)). Furthermore, a number of individual
helminth products with immunomodulatory properties have now
been deﬁned (reviewed in Harnett and Harnett (2010)). A pattern,
which is emerging is that these products are often anti-inﬂamma-
tory and hence they have been studied in mouse models of dis-
eases that are associated with inﬂammation in the search for
novel anti-inﬂammatory drugs. This policy is consistent with the
currently popular idea that parasitic worm infections may protect
humans against the development of autoimmune and allergic dis-
eases (reviewed in Helmby (2009)).
The possibility that deﬁned helminth products could ultimately
see use in the clinic argues for an understanding of their effects on
the immune system at the molecular level. It would be prudent to
establish for example, the identity of the receptors that they inter-
act with and the effects that receptor ligation have on downstream
signaling pathways. Certainly such information is beginning to
emerge with respect to several deﬁned helminth immunomodula-
tors (reviewed in Everts et al. (2010), Harnett and Harnett (2010),
Perrigoue et al. (2008), van Die and Cummings (2009)). One of
these helminth molecules is ES-62, a secreted product of the ro-
dent ﬁlarial nematode Acanthocheilonema viteae that is amongst
the best characterized of the helminth-derived immunomodula-
tors. It is a phosphorylcholine (PC)-containing molecule whose
anti-inﬂammatory properties allow it to provide signiﬁcant protec-
tion against the development of arthritis and allergy in mouse
models and the PC moiety appears to be largely responsible for
immunomodulatory activity (reviewed in Harnett and Harnett
(2009)). Studies investigating the effects of ES-62 on antigen-pre-
senting cells (APC) – macrophages and dendritic cells showed,
via the use of knockout mice, that ES-62-induced immunomodula-
tory effects on these cells was dependent on the presence of
MyD88 and TLR4 but not TLR2 (Goodridge et al., 2005). The reli-
ance on TLR4 appeared atypical in that unlike bacterial LPS, ES-
62 was found to be active against APC obtained from C3H/HeJ mice,
which have a point mutation in TLR4. PC conjugated to ovalbumin
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(OVA) can mimic ES-62’s effects on APC and this is also dependent
on both MyD88 and TLR4 and like ES-62, PC-OVA is also effective in
C3H/HeJ mice (Goodridge et al., 2007).
Although ES-62 activity in APC has been shown to be dependent
on TLR4, this is not the only potential cell surface receptor for it.
Thus, ES-62, possibly via its high mannose glycan moiety (Haslam
et al., 1997), has been found to bind a soluble form of the mannose
receptor and we also have some evidence suggesting that, perhaps
as beﬁts a PC-containing molecule, it is able to interact with cells
via the PAF receptor (unpublished results). Although we have yet
to put biological signiﬁcance to these additional interactions
((Goodridge et al., 2007) and unpublished results) they clearly
indicate the possibility of multiple receptor usage by ES-62. Fur-
thermore, it is possible that different cells of the immune system
may bind ES-62 via distinct receptors or alternatively, differential
TLR4-containing receptor complexes. In relation to this, in this
manuscript we examine receptor usage by ES-62 on lymphocytes
and myeloid cells and we present evidence to suggest that the
receptors that ES-62 uses varies amongst cell types.
2. Materials and methods
2.1. ES-62, mice and cells
Puriﬁed ES-62 from A. viteae was prepared as described previ-
ously (Goodridge et al., 2005). Wild type BALB/c and C57BL/6 mice
were obtained from Harlan Olac (Bicester, UK). TLR4/ and
MyD88/ mice (C57BL/6 background) were a generous gift from
Prof. S. Akira, University of Osaka, Osaka, Japan to Dr. K. Else and
Dr. S. Tötemeyer at the Universities of Manchester and Cambridge,
UK, respectively. Mice and gerbils (used in production of ES-62) are
housed and employed in experiments as indicated under home of-
ﬁce licenses obtained from the UK government. Bone marrow-de-
rived macrophages (bmMs) were prepared as described
previously (Goodridge et al., 2004). Murine B cells (>98% sIg+) were
prepared using the CD43-magnetic bead negative-selection meth-
od of Miltenyi Biotec as described previously (Deehan et al.,
2001). U937 cells, WEHI-231 B cells and Jurkat T cells were cultured
as described previously (Harnett et al., 1998; Katz et al., 2004;
Smith et al., 2003).
2.2. Biacore analysis
Analysis was carried out using CM5 research-grade biosensor
chips in a biacore biosensor BIAcore 2000 (Uppsala, Sweden) as de-
scribed previously (Mistrik et al., 2004). Brieﬂy, ES-62 was immo-
bilized on channels of CM5 chips using an amine coupling
procedure and various membrane preparations screened for bind-
ing as indicated by an increase in the surface plasmon resonance
(SRP) signal due to the alteration in refractive index caused by
binding of a biomolecule(s) to the chip, followed by analysis of
the dissociation phase. The fourth channel of the chip was left un-
coated and used as the control reference cell to allow subtraction
of background/non-speciﬁc binding of the membrane preparations
to the chips. The kinetics parameters were derived from obtained
data using BIA evaluation software 3.1 (Biacore AB). In some exper-
iments, the anti-PC antibody TEPC 15 was injected prior to mem-
brane fractions to determine whether the PC-moiety of ES-62
was important for binding.
2.3. Preparation of whole cell lysates for Far Western blotting
Cells were pelleted by centrifugation at 400g for 10 min, resus-
pended in 150 ll lysis buffer pH 7.5 (100 mM Tris base, 300 mM
NaCl, 4% (v/v) NP40, 0.5% (v/v) sodium deoxycholate, 2 mM EDTA)
containing 1 lg/ml each of chymostatin, leupeptin, antipain and
pepstatin A and 1 mM sodium orthovanadate and 10 mM PMSF
and solubilized on ice for 20 min. Cellular debris was removed by
microfugation at 10,000 rpm for 10 min and the supernatants con-
taining the solubilized whole cell lysates resolved by SDS–PAGE.
For Far Western blotting, a biotin conjugate of ES-62 was used in
place of the primary antibody and was then detected by an HRP-
conjugated anti-biotin antibody (diluted 1:2000 in wash buffer
containing 5% Marvel). Immunoreactive bands were visualized by
the enhanced chemiluminescence (ECL) system (Amersham, Buck-
inghamshire, UK).
2.4. Biotinylation of cell surface proteins and preparation of membrane
extracts
Cells (108) were washed three times and then resuspended in
0.5 ml PBS pH 7.2. Freshly prepared NHS–biotin solution (Pierce)
at 4 mg/ml was added and the cells were incubated at room tem-
perature for 30 min on a rocking platform before washing three
times in PBS to remove any unbound biotin. The cells were then
resuspended in 1.5 ml of ice-cold extraction buffer (50 mM HEPES
pH 7.4, 5 mM CaCl2, 140 mM NaCl, 1% (v/v) octyl-b-D-glucopyran-
oside, 1 mM PMSF, 1 mM aprotonin, 1 mM leupeptin) and snap fro-
zen in liquid nitrogen. The sample was then thawed, homogenized
in a glass homogeniser (20–30 strokes) and incubated on ice for
1 h. The extract was then centrifuged at 2000 rpm to pellet nuclei
and unbroken cells and the resulting supernatant centrifuged at
45,000g for 1 h at 4 C and the supernatant retained as the solubi-
lized membrane extract. For precipitation of ES-62-binding pro-
teins, extracts were precleared by the addition of 50 ll of 50%
protein L-agarose washed slurry followed by incubation for 1 h at
4 C on a rotator. Samples were microfuged at 13,000 rpm for
10 min and the pellet discarded. ES-62-FITC (5 lg/ml) was added
to the supernatant and incubated for 2 h at 4 C on a rotator. The
samples were then incubated with anti-FITC antibodies pre-bound
to protein L-agarose (1 lg/50 ll 50% protein L-agarose slurry) over-
night at 4 C on a rotator. In some experiments, the biotinylated
membranes were preincubated with fucose, PC or an RGDS peptide
in an attempt to block binding between ES-62 and polypeptides.
The immune complexes were washed three times in PBS pH 7.2,
resuspended in SDS–PAGE loading buffer, heated to release the
proteins and the beads removed by microfugation prior to resolu-
tion of ES-62-binding proteins by SDS–PAGE and detection by an
HRP-conjugated anti-biotin antibody.
2.5. Preparation of cell extracts for Western blotting analysis of ES-62
binding to, and internalization via, TLR4
Following incubation of the cells with ES-62 (2 lg/ml) at 37 C,
the cells were washed three times with ice cold 25 mM Tris–HCl
pH 7.4 containing 150 mM NaCl and 100 mM sodium orthovana-
date before preparing cell lysates with RIPA buffer as described
previously (Feng et al., 1999) and protein concentrations were
determined using the microBCA protein assay reagent (Pierce,
Rockford, USA). Cell lysates were resolved using the NuPAGE (Invit-
rogen) and transferred to nitrocellulose according to the manufac-
turer’s instructions. Nitrocellulose ﬁlters were then incubated with
wash buffer (2 M Tris, pH 7.5 containing 500 mM NaCl and 0.1% (v/
v) Tween-20) containing 5% milk protein for at least 1 h to block
non-speciﬁc protein binding. The primary antibodies (rabbit anti-
ES-62 serum) were diluted 1:100 in wash buffer containing 5%
Marvel and applied to the ﬁlter for 1 h at room temperature or
overnight at 4 C. Following washing, the blots were incubated
with HRP-conjugated anti-rabbit IgG (diluted 1:2000 in wash
buffer containing 5% Marvel) for 1 h at room temperature (Egan
et al., 2006). Immunoreactive bands were visualized by the
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enhanced chemiluminescence (ECL) system (Amersham, Bucking-
hamshire, UK).
2.6. Immunoﬂuorescence
Bonemarrow-derivedmacrophages (BMM; 103) were incubated
in 1 ml of Dulbecco’s modiﬁed eagle medium containing penicillin
(100 U/ml), streptomycin (100 lg/ml), 2 mM glutamine and 10%
heat-inactivated fetal calf serum (FCS) (DMEM-complete) on
13 mm coverslips in the wells of a 24 well-plate overnight at
37 C in an atmosphere of 5% CO2/95% air. The medium was re-
moved and replaced with 1 ml of DMEM-complete containing ES-
62 (2 lg/ml) and incubated for a further 3 h. The medium contain-
ing ES-62 was removed and the cells ﬁxed in 3% paraformaldehyde/
PBS containing 0.05% Triton X-100 for 20 min at room temperature.
Following ﬁxing, the cells were washed (2) with PBS containing
1% FCS and then incubated with PBS containing 10% FCS for
15 min at room temperature to prevent subsequent non-speciﬁc
binding of antibody. The cells were then again washed (2) and
incubated with KK6-FC4.3, a mouse monoclonal antibody against
ES-62 or mouse IgG (10 lg/ml) in PBS containing 1% FCS for 2 h at
room temperature. Following washing (4), cells were incubated
with FITC-labeled goat anti-mouse IgG (dilution as recommended
bymanufacturer: Sigma, Poole, Dorset, UK) for 90 min at room tem-
perature, washed again (4) and coverslips mounted on slides for
examination by confocal ﬂuorescence microscopy.
2.7. Internalization of [35S]-methionine-labeled ES-62 and analysis of
resultant labeled cellular cytosolic fractions
WEHI-231 B cells (107) per time-point were incubated in a 24
well plate in 1 ml of RPMI 1640 medium supplemented with 5%
heat-inactivated fetal calf serum, penicillin (100 U/ml) and strepto-
mycin (100 lg/ml). [35S]-methionine-labeled ES-62 (50 ll;
15,000 cpm), prepared as described previously (Houston et al.,
1997) was added to each well and the cells incubated at 37 C in
5% CO2/95% air for the appropriate times. Cells were washed (3)
with RPMI medium supplemented as before and transferred to
centrifuge tubes. Cells were then washed twice with 10 ml ice-cold
Tris-buffered saline (TBS) pH 7.6, pelleted by centrifugation at
1500g for 5 min and washed with 1 ml TBS before being trans-
ferred to an Eppendorf tube and pelleted again as before. Cytosolic
fractions were then prepared according to the nuclear and cyto-
plasmic extract kit commercially available from active motif and
radioactivity of duplicate 10 ll aliquots determined using a liquid
scintillation counter.
3. Results
3.1. Biacore analysis of ES-62 interaction with plasma membrane
extracts of different cell types
The kinetics of binding of ES-62 to molecules in plasma mem-
brane extracts of monocytes, B cells and T cells was investigated
by biacore analysis. This was undertaken by immobilizing ES-62
on the sensor chip and then employing the plasma membranes
as analyte. As the kinetics of binding are reﬂected by the shape
of the curve whilst the response units are equivalent to the mass
bound, then the observed differences in both parameters likely
indicate differences in receptor usage amongst the three cell types.
However, as we were using membranes rather than puriﬁed pro-
teins, the relative abundance of the individual proteins in the
membranes derived from the distinct cell types may confound con-
clusions regarding the mass of protein bound, indicating that the
kinetics are likely to be a better reﬂection of the differential recep-
tor usage. The curves obtained are indeed suggestive of speciﬁc
binding consistent with receptor–ligand interactions (Fig. 1)
although as mentioned, precise binding kinetics cannot be mea-
sured, due to the analyte being impure and a mixture of membrane
components. Nevertheless, the variation in the shape of the curve
is suggestive of different kinetics of interaction that depends on
the source of the membrane, with immobilized ES-62.
3.2. Identiﬁcation of ES-62-binding proteins from different cell types
Several approaches were adopted to determine the nature of
ES-62-binding proteins in these different cell types. First, we em-
ployed a Far Western blotting procedure using biotinylated ES-62
to identify binding proteins in whole cell extracts. This revealed
that in both splenic B cells and Jurkat T cells, ES-62 interacted with
proteins of 135 and 82 kDa whereas in U937 monocytes, bind-
ing was only observed with a protein of82 kDa (Fig. 2A). Next, we
immunoprecipitated ES-62-interacting membrane proteins from
surface-biotinylated B cells and U937 cells and employed an
anti-biotin-HRP antibody for their detection. As with the Far Wes-
tern analysis we detected polypeptides of 135 and 82 kDa with re-
spect to B cells but only the 82 kDamolecule in U937 cells (Fig. 2B).
Fig. 1. ES-62 was immobilised on the biacore sensor chip and the plasma membrane fractions from the indicated different cell origins were passed over the chip surface as
analyte. Regeneration was achieved using 100 mM glycine.
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The identity of the 82 and 135 kDa proteins has yet to be estab-
lished. The PAF and mannose receptors can be ruled out as they
have predicted molecular weights of 39 and 166 kDa, respectively.
The molecular weights of the detected proteins are roughly consis-
tent both with integrin subunits (135 and 82 kDa molecules) and
toll-like receptors (82 kDa molecule). Using the surface-biotinyla-
ted membrane extracts, we tested for the presence of integrins
by determining whether fucose or an RGDS peptide could block
interaction between ES-62 and the proteins in WEHI-231 B cell
membranes (Kigimoto-Ochiai and Noguchi, 2000). However, we
could ﬁnd no evidence for the polypeptides being integrins
(Fig. 3). Interestingly however free PC signiﬁcantly inhibited bind-
ing to the two proteins thus demonstrating a likely role for the PC
moiety of ES-62 in interactions with them. We also noted by bia-
core analysis that the anti-PC myeloma protein TEPC 15 prevented
interaction between ES-62 and U937 proteins (Fig. 4). We had pre-
viously shown ES-62 activity to be dependent on TLR4 (Goodridge
et al., 2005) and hence to determine whether the 82 kDa polypep-
tide might be TLR4 we undertook Western blotting using an anti-
TLR4 antibody. The 82 kDamolecule in U937 cells and Jurkat T cells
was not recognized by the antibody whereas the 82 kDa molecule
in splenic B cells was weakly recognized by the antibody but in
addition, by an anti-TLR2 antibody (results not shown). The results
with the U937 and Jurkat T cells are perhaps not surprising as only
2% of the former express TLR4 (Romano Caratelli et al., 2010) and
TLR4 is absent from the latter (Ye and Gan, 2007). The result with
the B cells (which are known to express TLR4) may simply reﬂect
cross-reactivity between antibodies but if this is the case and the
molecule being detected is truly TLR4, then it would appear to be
distinct from the 82 kDa molecule being detected in the other cells.
3.3. TLR4 is essential for internalization of ES-62 in macrophages but
not B cells
Previously we have shown that ES-62 is internalized by mast
cells (Melendez et al., 2007) and we now demonstrate by the use
of immunoﬂuorescence that the same is true of macrophages
(Fig. 5A and B). Furthermore, incubation of B cells with [35S]-
methionine radiolabeled ES-62 and subsequent cell fractionation
resulted in the molecule being clearly detected in a cytoplasmic ex-
tract within 1 h (Fig. 5C). Thus, our results as a whole indicate that
B cells U937 Jurkat
135 kDa
82 kDa
B cells U937
290 kDa
53 kDa
A B
Fig. 2. (A) ES-62 interacting proteins in whole cell lysates from splenic B cells, U937
monocytes and Jurkat T cells were identiﬁed by Far Western blotting using
biotinylated ES-62. (B) ES-62-interacting membrane proteins from surface biotin-
ylated cells were immunoprecipitated and detected by Western blotting.
135 kDa
82 kDa
290 kDa
53 kDa
None PC fucose RGDS RDES
Fig. 3. Plasma membrane extracts from surface biotinylated WEHI-231 B cells were
pre-incubated with medium or PC (1 mM), fucose (1 mM), RGDS (1 mM) or control
RDES peptide (1 mM) prior to incubation with ES-62-FITC and subsequent pull-
down of ES-62-binding proteins using anti-FITC-bound protein L-agarose beads. ES-
62-binding proteins were then immunoprecipitated and detected by Western
blotting.
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Fig. 4. (A) ES-62 was immobilised on the biacore sensor chip and the monoclonal antibody (TEPC-15) was ﬁrst bound to the ES-62 immobilised chip prior to applying U937
monocyte membranes. No binding of membrane proteins was observed. (B) ES-62 was immobilised on the biacore sensor chip and cell membranes puriﬁed from U937
monocytes were passed over the chip surface as analyte. The expected binding curve (Fig. 1) for monocyte membranes was observed.
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cells of the immune system tend to internalize ES-62. Our previous
studies have also revealed via the use of knockout mice that for ES-
62 to inhibit pro-inﬂammatory cytokine production by macro-
phages, the cells must express both TLR4 and MyD88 (Goodridge
et al., 2005). TLR4 is present at the macrophage surface and hence
similar to the situation with LPS, it may act as a receptor for ES-62.
Consistent with this, ES-62 is bound and internalized by wild type
and MyD88/macrophages but not TLR4/macrophages (Fig. 5D
and E). However, ES-62 is internalized by each of wild type,
MyD88/ and TLR4/ splenic B cells (Fig. 5F and G). Thus, clearly
the two cell types are using different receptors or combinations of
receptors for ES-62 binding and internalization.
4. Discussion
ES-62 has been subject to study since 1989 and its immuno-
modulatory properties ﬁrst documented in 1993 (reviewed by
Harnett and Harnett (2009)). The ﬁrst immunomodulatory study
focused on the B cell and since then ES-62 has been studied with
respect to T cells and T cell lines, B1 cells, macrophages, dendritic
cells and mast cells (reviewed by Harnett and Harnett (2009)). The
only cell population investigated that was found to be unaffected
by exposure to ES-62 was human tonsil T cells (Harnett et al.,
1998) and this could perhaps be explained by these cells failing
to express the ‘‘ES-62 receptor’’. Subsequent work in APC that
made use of knockout mice indicated that TLR4 expression was
essential for the immunomodulatory action of ES-62 (Goodridge
et al., 2005, 2007) and this was supported by knockdown studies
in mast cells (Melendez et al., 2007). These studies therefore sug-
gested that TLR4 was the receptor for ES-62. However they did
not rule out the existence of co-receptors or other receptors for
the helminth product and indeed there is evidence to suggest that
ES-62 can bind to both the mannose receptor and the PAF receptor
even although the biological signiﬁcance of such interactions has
yet to be established ((Goodridge et al., 2007) and unpublished re-
sults). Furthermore, it was unknown as to whether the critical role
that TLR4 plays in facilitating ES-62 in APC and mast cells also ap-
plied to other cell types. Indeed Jurkat T cells are receptive to the
Wild type MyD88 -/-
- ES-62 - ES-62
-/-
- ES-62 - ES-62
Wild type MyD88-/-
- ES-62 - ES-62
Wild type TLR4Wild type TLR4-/-
- ES-62 - ES-62
64 kDa
64 kDa
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51 kDa
B
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Fig. 5. Bone marrow-derived macrophages were incubated with ES-62 and internalization of the helminth product visualized by a mouse monoclonal antibody against ES-62
(A) followed by FITC-labeled anti-mouse IgG. Mouse IgG (B) as the primary antibody was used as a speciﬁcity control. WEHI-231 B cells were incubated with [35S]-
methionine-labeled ES-62 for time-periods as indicated and cytoplasmic extracts prepared for determination of radioactivity levels (C). Results presented are the average
values of two aliquots at each time point. Bone marrow-derived macrophages (D and E) and splenic B cells (F and G) fromwild type (D–G), MyD88/ (D and F) and TLR4/ (E
and G) mice were incubated with ES-62 at 37 C. Following washing the binding and internalization of ES-62 was assessed by Western blot analysis.
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actions of ES-62 (Harnett et al., 1998) but like primary T cells,
apparently lack TLR4 (Ye and Gan, 2007).
We now illustrate apparent differences in receptor usage by ES-
62 on different cell types. Lymphocytes – both T and B cells, pos-
sess two surface-located ES-62-binding proteins of 135 and
82 kDa whereas U937 monocytes only express a molecule of
82 kDa. Based on blocking studies with free PC, interaction with
both of these proteins in B cells is almost certainly via the PC moi-
eties of ES-62. This may suggest a shared structural feature but the
identity of the two proteins has yet to be established. Furthermore,
based on Western blot analysis with anti-TLR antibodies the
82 kDa protein being detected in B cells may be distinct from that
in U937 and Jurkat T-cells, thereby increasing the number of pos-
sible ES-62 receptors in the immune system (in addition, Fig. 2 sug-
gests that Jurkat cells may express an additional lower molecular
mass receptor of 53 kDa and Fig. 3 suggests the same of WEHI-
231 B cells). Although the Western blot data suggested that the
82 kDa molecular weight protein in B cells could be TLR4, this
could not be conﬁrmed due to likely cross-reactivity amongst
anti-TLR antibodies and hence the use of more speciﬁc antibodies
or reagents may be warranted.
Binding of ES-62 to immune system cells results in internaliza-
tion. ES-62 activity against APC is, as mentioned earlier, dependent
on TLR4 and in the present study we indicate that the same is true
for internalization. Thus, if the 82 kDa molecule is not TLR4 then
clearly it is not a receptor which is able to facilitate ES-62 internal-
ization. The intracellular adaptor protein MyD88 is also necessary
for ES-62 activity against APC (Goodridge et al., 2005) but unlike
for TLR4, internalization of ES-62 is not dependent on expression
of MyD88 suggesting that MyD88-dependent signaling is not
essential for internalization. Absence of TLR4 did not prevent B
cells from internalizing ES-62, raising the possibility of an alterna-
tive or additional receptor on these cells. It is tempting to speculate
that this may be the 135 kDa protein that is absent from U937
monocytes but this remains to be established. In any case, the data
obtained with the two cell types clearly suggest that ES-62 as con-
sidered at the outset, interacts with different receptors on different
cells of the immune system.
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